Murray W. Stewart
DirectorDr. Murray W. Stewart, D. M., F. R.C. P., M.D., is Independent Director at Camp4 Therapeutics Corporation from March 2025. He serves as Independent Director of VectivBio Holding AG since September 2, 2021. He served as Independent Director at Amarin Corporation plc since January 2023 until March 07, 2023. He served as Director at KBP BioSciences Co., Ltd. Since August 2022 until 2022. He serves as Scientific Advisor of KBP BioSciences Co., Ltd. since 2022. He served as Scientific Advisor of KBP BioSciences Co., Ltd. since 2021 until August 2022. He has been an Independent Director at X4 Pharmaceuticals, Inc. since March 29, 2019 and served as its Interim Chief Medical Officer since November 2022. Dr. Stewart had been Chief Medical Officer of Rhythm Pharmaceuticals, Inc. since October 15, 2018 until September 10, 2021. Dr. Stewart joined Rhythm from Novelion Therapeutics Inc, where he served as Executive Vice President, Head of R&D from November 2017 to October 2018 and oversaw global medical affairs for Juxtapid and Myalept, two marketed products for rare metabolic diseases. Previously, he served as Chief Medical Officer at GlaxoSmithKline (GSK) from April 2014 to November 2017, with global responsibility for patient well-being across the vaccine, pharmaceutical and consumer business units. Prior to that, after joining GSK in 2000 as associate Director for clinical research and development in the United Kingdom, Dr. Stewart served in positions of increasing responsibility at GSK, including as GSK’s therapy area Head for the cardiovascular and metabolic therapy areas from 2010 to 2014 and the clinical Head of the biopharmaceutical unit from 2009 to 2010. Prior to joining the pharmaceutical industry, Dr. Stewart worked as a diabetes consultant and senior lecturer and was consultant physician/honorary senior lecturer and Head of clinical services at the Diabetes Centre, Newcastle upon Tyne in the United Kingdom. Dr. Stewart serves on the Board of Directors of Vivli, a non-profit organization implementing a clinical research data-sharing platform. Dr. Stewart completed his medical training at Southampton Medical School in the United Kingdom. He holds an M. D. and Bachelor of Medicine from Southampton Medical School and is a Fellow of the Royal College of Physicians.
Positions
- Company NameX4 Pharmaceuticals, Inc.Stock CodeXFORPositionDirectorColleagues
- ARAdam R. CraigExecutive Chair
- JPJohn P. VolponePresident & COO
- DHDavid H. KirskeCFO, Treasurer & Corporate Secretary
- RPRichard PetersFounder
- RTRenato T. SkerljFounder
- KTKeith T. FlahertyFounder & Member of Corporate Advisory Board
- MSMichael Stephen WyzgaLead Independent Director
- MJMichael J. VasconcellesMember of Corporate Advisory Board
